Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IM

November 8, 2022

For Immediate Release

Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IM

West Chester, PA (November 1, 2022) – Daicel Chiral Technologies introduces CHIRALPAK® IM. This new selector Cellulose 3 chloro 4 methyl phenyl carbamate is the immobilized version of CHIRALCEL® OZ. This cellulose-based immobilized chiral selector is designed for HPLC and SFC to improve the resolution and selectivity for challenging separations. The increased robustness from the immobilization process allows CHIRALPAK® IM to withstand a wider range of mobile phase combinations, which can enhance separations already achieved using CHIRALCEL®OZ.  CHIRALPAK IM is available in 5-micron particle size, with other sizes coming soon!

###

About Daicel Chiral Technologies

Chiral Technologies, Inc., d/b/a Daicel Chiral Technologies, is the global leader in enantioselective chromatography serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Daicel Chiral Technologies (West Chester, Pa.), the European market through Daicel Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.